Contact Us

support@psogi.com

List of PSOGI meetings

Year Congress Congress Chair(s) Participants City, Country Dates
1998 1st International Congress Bill Heald, Brendan Moran, Paul Sugarbaker 20 Basingstoke, United Kingdom -
2000 2nd International Congress Bill Heald, Brendan Moran, Paul Sugarbaker 30 London, United Kingdom June 1-2
2002 3rd International Congress Brendan Moran 50 Basingstoke, United Kingdom December 5-6
2004 4th International Congress Santiago Gonzalez Moreno 250 Madrid, Spain December 2-4
2006 5th International Congress Marcello Deraco, Paul Sugarbaker 450 Milan, Italy December 4-6
2008 6th International Congress Francois Noel Gilly, Olivier Glehen 450 Lyon, France November 17-19
2010 7th International Congress Haile Mahteme 450 Uppsala, Sweden September 8-10
2012 8th International Congress Pompiliu Piso, Paul Sugarbaker 600 Berlin, Germany October 31 - November 2
2014 9th International Congress Victor Verwaal 650 Amsterdam, Netherlands October 9-11
2016 10th International Congress Paul Sugarbaker 700 Washington DC, USA November 17-19
2018 11th International Congress Diane Goere, Olivier Glehen, Marc Pocard 1000 Paris, France September 9-11
2021 12th International Congress Yan Li 300 in person; 16,000 virtual Online (Beijing, China) September 10-12
2023 13th International Congress Marcello Deraco, Paolo Sammartino 800 Venice, Italy October 4-6
2024 14th International Congress Olivier Glehen 625 Lyon, France September 24-26
2025 15th International Congress Fernando Pereira, Pere Bretcha Boix 812 Barcelona, Spain October 29-31
View Gallery

PSOGI is dedicated to improve treatment and survival of patients with peritoneal metastases

PSOGI is a collaboration of world–renowned experts on the treatment of peritoneal cancer.

PSOGI aims to improve the treatment and survival of peritoneal cancer patients by educating patients, by training physicians, by organizing meetings and by performing basic and clinical scientific research into peritoneal cancer and the different treatment modalities.

Join Our Community

We will only send relevant news and no spam

You have been successfully Subscribed! Ops! Something went wrong, please try again.